drugset / Trial / NCT06534944
NAD Supplementation and Vascular Health in PAD
NaSingle-groupOpen-labelBasic science
Summary
This pilot open-label clinical trial was designed to investigate whether 4-week supplementation with 1g daily NR impacts endothelial function in peripheral circulation, cerebrovascular hemodynamics, cognitive function in older adults with peripheral artery disease.
Timeline
- Start
- 2023-02-27
- Primary completion
- 2024-07-30
- Completion
- 2024-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nicotinamide riboside | Small molecule | 1 g | Oral |